Isolation and characterization of a rare group A rotavirus G13P[18] strain from a diarrhoeic foal in Japan.

The research article discusses the identification and analysis of a rare type of rotavirus (G13P[18]) in a diarrheic foal in Japan, a strain not isolated for the past 28 years.

Research Context

• The study focuses on a rare group A rotavirus genotype G13P[18]. This virus primarily causes gastroenteritis in infants and young animals, with manifestations including vomiting, diarrhea, and abdominal pain.
• This particular strain, referred to as RVA/Horse-tc/JPN/MK9/2019/G13P[18], was isolated from a foal in Japan experiencing diarrhea – the first time such an isolation has happened in 28 years.

Genotype Constellation and Phylogenetic Analysis

• The researchers assigned the genotype constellation of the isolated virus as G13-P[18]-I6-R9-C9-M6-A6-N9-T12-E14-H11, which interestingly, matches that of the first strain of this kind isolated, RVA/Horse-tc/GBR/L338/1991/G13P[18].
• A genotype constellation identifies the specific group of genes that a virus carries. In this case, each letter-number combination refers to different genes present in the virus, which helps classify and identify the virus in future research.
• The scientists then carried out a phylogenetic analysis, which is a technique used to construct the evolutionary relationships between different species, in this case, different rotaviruses. This analysis helped conclude that the virus is related to its previously isolated counterpart and differs significantly from regular equine rotaviruses of the G3P[12] and G14P[12] genotypes.

Significance of the Study

• The isolation and characterization of this unique strain of rotavirus extend our understanding of diverse rotavirus strains, their prevalence, and potential impact on equine health.
• This study could contribute significantly to advancing equine veterinary medicine and future research on preventing, diagnosing, and treating rotavirus infections.
• Such research also opens potential opportunities for developing new vaccines or therapies to manage and mitigate the spread of the disease among horse populations.